New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 11, 2019 - Sun launched an AB-rated generic version of Gilead Sciences’ Letairis (ambrisentan) tablets.
Download PDF
Return to publications
